Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Pain Management

Staff reviewers at the FDA have confirmed that Novartis‘ new psoriasis drug, secukinumab, poses no major safety issues to patients. According to Reuters, secukinumab (AIN457) is expected to lead the way in immunosuppresant therapy, a class of drugs...
Hundreds of children in the Midwest have fallen ill as a respiratory illness known as human enterovirus 68 is spreading, an article published by CBS News reports. The virus, which resembles the common cold, strikes quickly, leaving its victims gasping for...
For women with breast cancer, a month or more of daily radiation treatment is common, however, according to an article published in CBS News, weekly treatment may be just as effective. This new, less frequent treatment option yields similar results,...